Tumor DNA in cells trapped in tampons placed in the vaginas of patients with ovarian cancer.
Preliminary finding may bring doctors one step closer to and ovarian cancer screening test.
Examination of mined junk DNA sequences has helped identify a non-protein-coding RNA whose expression is linked to ovarian cancer.
A PARP inhibitor in oral tablet form, given in combination with chemotherapy, was deemed safe for heavily pretreated patients with ovarian cancer.
Olaparib has been deemed safe in combination with carboplatin/paclitaxel in advanced ovarian cancer.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|